Saturated Cannabinoids: Update on Synthesis Strategies and Biological Studies of These Emerging Cannabinoid Analogs
Natural and non-natural hexahydrocannabinols (HHC) were first described in 1940 by Adam and in late 2021 arose on the drug market in the United States and in some European countries. A background on the discovery, synthesis, and pharmacology studies of hydrogenated and saturated cannabinoids is desc...
Main Authors: | Maite L. Docampo-Palacios, Giovanni A. Ramirez, Tesfay T. Tesfatsion, Alex Okhovat, Monica Pittiglio, Kyle P. Ray, Westley Cruces |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/17/6434 |
Similar Items
-
Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid Receptor
by: Shakiru O. Alapafuja, et al.
Published: (2019-10-01) -
Synthesis of Functionalized Cannabilactones
by: Yingpeng Liu, et al.
Published: (2020-02-01) -
Cannabinoids and Their Receptors in Skin Diseases
by: Eun Hee Yoo, et al.
Published: (2023-11-01) -
Structure–Activity Relationship Development Efforts towards Peripherally Selective Analogs of the Cannabinoid Receptor Partial Agonist BAY 59-3074
by: George Amato, et al.
Published: (2022-09-01) -
Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy
by: Giulia Abate, et al.
Published: (2021-06-01)